Evolus, Inc. (EOLS) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Evolus, Inc. EOLS 7.10 −6.21%
- Ironwood Pharmaceuticals, Inc. IRWD 3.50 −7.16%
Evolus, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $623.0M against $500.0M — 1.2× the size. Evolus, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.4×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against 13.9%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs −10.9%) and the higher return on invested capital (101.6% vs −14.5%). Across the 18 metrics below, Ironwood Pharmaceuticals, Inc. leads on 12 and Evolus, Inc. on 6.
Valuation
Profitability
| Metric | EOLS | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.74% | 100.00% | 53.94% |
| Operating margin | (5.90%) | 60.15% | 0.00% |
| Net margin | (10.85%) | 33.36% | 0.00% |
| Free cash flow margin | (6.92%) | 47.66% | 0.00% |
| Return on equity | 138.57% | (55.26%) | (0.40%) |
| Return on assets | (14.40%) | 41.35% | (3.32%) |
| Return on invested capital | (14.47%) | 101.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack